The impact of shame and cultural beliefs on mental illness and treatment adherence: A case report

2017 ◽  
Vol 41 (S1) ◽  
pp. S511-S511 ◽  
Author(s):  
A. Albassam ◽  
A. Ameen ◽  
V. Chiappetta ◽  
A. Hanif ◽  
L. Gonzalez
Keyword(s):  
Mental Illness ◽  
Case Report ◽  
Psychiatric Treatment ◽  
Treatment Plan ◽  
Paranoid Schizophrenia ◽  
Cultural Beliefs ◽  
Psychotic Symptoms ◽  
Presenting Symptoms ◽  
Adherence To Medication ◽  
The Impact

IntroductionShame, especially when enmeshed in cultural beliefs about mental illness and cultural roles, could be a detrimental factor in psychiatric illness in context of adherence to treatment and continuation of care. Shame is defined as a painful experience which embodies multiple components including: collapse of self esteem, feeling of humiliation, rupture of self continuity, sense of isolation, and feeling of being watched by critical others.ObjectiveUnderstanding the psychodynamics of shame, in a particular cultural milieu and its components which could impact psychiatric treatment and care.MethodHere we present a case report of a 41-years-old Arab male patient from Yemen, with a history of paranoid schizophrenia who was admitted to inpatient psychiatric service for bizarre and aggressive behavior.ResultsInitially the depth of patient's delusions and psychotic symptoms were not fully appreciated due to the cultural gap between the patient and the treatment team. He was then re-valuated through the implementation of the cultural formulation interview (CFI) by clinicians from same cultural background. This team was able to elucidate the deep feelings of shame and inadequacy in patient's presentation and provide a culturally tailored treatment plan.ConclusionsEvaluation of psychiatric patients in a different cultural setting where western values do not apply might not be sufficient to assess the breadth of psychotic symptoms especially when an underlying feeling of shame contribute to presenting symptoms. Treatment of those patients with neuroleptics without assessing the cultural dynamics might result in poor adherence to medication and follow up.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals Spirituality and Employment in Recovery from Severe and Persistent Mental Illness and Psychological Well-Being

Healthcare ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 57
Author(s):  
Jesús Saiz ◽  
María Galilea ◽  
Antonio J. Molina ◽  
María Salazar ◽  
Tiffany J. Barsotti ◽  
...  
Keyword(s):  
Mental Illness ◽  
Work Motivation ◽  
Psychiatric Treatment ◽  
Predictor Variable ◽  
Recovery Process ◽  
Well Being ◽  
Job Skills ◽  
Psychotic Symptoms ◽  
Psychological Well Being ◽  
Persistent Mental Illness

People diagnosed with severe and persistent mental illness (SPMI) face multiple vulnerabilities, including when seeking employment. Among SPMI patients, studies show that a stronger sense of spirituality can help to reduce psychotic symptoms, increase social integration, reduce the risk of suicide attempts and promote adherence to psychiatric treatment. This study examined how the variables spirituality and employment affect the recovery process and psychological well-being of people with SPMI who attend employment recovery services. The sample consisted of 64 women and men diagnosed with an SPMI. The assessment instruments included the Recovery Assessment Scale, Ryff Psychological Well-Being Scale, Work Motivation Questionnaire, Daily Spiritual Experience Scale, and Functional Assessment of Chronic Illness Therapy—Spiritual Well-Being (FACIT-Sp12). Hierarchical regression analyses were performed to compare three different models for each dependent variable (recovery and psychological well-being). The findings showed that job skills predicted psychological well-being and recovery. When spiritual variables were included in the model, job skills dropped out and the dimension meaning/peace of the FACIT-Sp12 emerged as the only significant predictor variable. Integrating spirituality into recovery programs for people with SPMI may be a helpful complement to facilitate the recovery process and improve psychological well-being.

The History of the Treatment of Mental Illness

2016 ◽  
pp. 1-16
Author(s):  
Lauren Mizock ◽  
Zlatka Russinova
Keyword(s):  
Mental Illness ◽  
Middle Ages ◽  
Western Europe ◽  
Psychiatric Treatment ◽  
Shock Therapy ◽  
The United States ◽  
Models Of Care ◽  
People With Mental Illness ◽  
History Of ◽  
The Impact

Chapter 1 reviews the history of psychiatric treatment of people with mental illness in the United States and Western Europe, highlighting past perspectives in care, such as ancient trephination and exorcism during the demonology era, humorism in early Greek and Roman thought, a return to demonological perspectives in the Middle Ages, as well as mesmerism and psychoanalysis in the 19th and 20th centuries. The 20th-century biological perspective is described, including the use of insulin shock therapy, electroconvulsive therapy, and lobotomy. Next, the development of more humane treatment approaches is discussed, such as the moral treatment movement of the 1800s. The ex-patient’s movement of the 1970s is reviewed, leading up to the contemporary recovery-oriented and psychosocial rehabilitation models of care. The impact of stigma on the acceptance of serious mental illness is explored throughout this history. Discussion questions, activities, and diagrams are also included.

scholarly journals The Digital Integrated Workflow in the Aesthetic Management of the Smile: A Case Report

Prosthesis ◽  
2020 ◽  
Vol 2 (3) ◽  
pp. 196-210
Author(s):  
Paolo Scattarelli ◽  
Paolo Smaniotto ◽  
Serena Leuci ◽  
Gabriele Cervino ◽  
Mario Gisotti
Keyword(s):  
Case Report ◽  
Treatment Plan ◽  
Digital Tools ◽  
Invasive Procedures ◽  
Digital Workflow ◽  
Deep Bite ◽  
Anterior Teeth ◽  
Dental Technician ◽  
The Aesthetic ◽  
The Impact

The aesthetic treatment for anterior teeth requires a series of clinical and technical evaluations to obtain a predictable result, following a well-defined operating sequence. Today, the clinical–technical team can use different digital tools in the different steps of the workflow. A preventive assessment, the knowledge of limits, and the possibilities of surgical and prosthetic procedures allow to use these devices. Sharing goals of the treatment with the patient according to their expectations and needs is the key point of the treatment plan. Setting a defined treatment plan avoids invasive procedures. In this clinical case report, a 27-year-old patient affected by Class II div 2 malocclusion with deep bite was treated with a full digital workflow. Previewing the aesthetics was through dedicated software, which shows operators and patients the objectives of the therapy and guides the dental technician in the first phase of the work. The use of digital flows in the prosthetic phases reduces the working time. In this case, it shows the impact of a digital workflow on peri-prosthetic therapy for the aesthetic rehabilitation of the upper central incisors in a young adult.

Trazodone and exacerbation of psychotic symptoms: an unfamiliar link

2014 ◽  
Vol 32 (4) ◽  
pp. 337-339 ◽  
Author(s):  
M. Osman ◽  
M. Kilduff
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Paranoid Schizophrenia ◽  
Psychotic Symptoms

ObjectiveIn this case report we attempt to emphasize the unfamiliar link between trazodone and relapse of psychotic symptoms.MethodCase report and literature review of relevant papers.ResultsWe report a case of a 78-year-old woman with an established diagnosis of paranoid schizophrenia who has experienced an exacerbation of positive psychotic symptoms following initiation of 50 mg dailydose of trazodone. We noted that psychotic symptoms abated following discontinuation of trazodone.ConclusionTrazodone use in patients in remission from schizophrenia may be associated with relapse of psychotic symptoms and caution is required.

scholarly journals The effectiveness of long-term aripiprazole injections to a patient with paranoid schizophrenia: a case report

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Anna Maria Szota ◽  
Aleksander Araszkiewicz
Keyword(s):  
Case Report ◽  
Negative Symptoms ◽  
Social Withdrawal ◽  
Paranoid Schizophrenia ◽  
Psychotic Symptoms ◽  
Suicidal Thoughts ◽  
Duration Of Hospitalization ◽  
History Of ◽  
Long Acting

AbstractParanoid schizophrenia is a chronic, psychotic disorder which can be treated with long-acting injectable (LAI) antipsychotic drugs. There are risperidone (Risperdal Consta®), olanzapine (Zypadhera®), paliperidone (Xepilon®) and aripiprazole (Abilify Maintena®) currently available.The aim of this study was to present a case history of the patient to whom monthly injections of aripiprazole effectively prevented both relapses of psychotic symptoms and hospitalizations.Case report: A 55-year-old male patient with a 13-year history of paranoid schizophrenia has been effectively treated with aripiprazole (LAI) (400mg, every 4 weeks). During the last 8 years of treatment his mental state has been stabilized, without any acute psychotic symptoms and without any anxiety, or violent behaviours. Moreover, there have been no psychotic symptoms, or suicidal thoughts, or tendencies recordered. Therefore, no hospitalization has been required. However, despite the treatment, negative symptoms such as blunted affect, cognitive dysfunction and social withdrawal have been sustained.Discussion: The available articles on aripiprazole (LAI) treatment indicate that it was effective in reducing the positive and negative symptoms of schizophrenia, as well as reducing the frequency and duration of hospitalization. However, the case report of a patient who has not had relapses of psychotic symptoms and suicidal thoughts and has not been hospitalized during 8 years of treatment with aripiprazole (LAI) has not yet been reported.Conclusions: Regular, long-term injections of aripiprazole (LAI) are very effective at preventing positive symptoms of schizophrenia development and preventing both suicidal thoughts and hospitalizations. Therefore, treatment with this drug in everyday practice should be increased.

Screening for Mental Illness: The Merger of Eugenics and the Drug Industry

2005 ◽  
Vol 7 (2) ◽  
pp. 111-124 ◽  
Author(s):  
Vera Hassner Sharav
Keyword(s):  
Mental Illness ◽  
Psychotropic Drugs ◽  
Treatment Plan ◽  
Medication Treatment ◽  
Faith Based ◽  
United States Population ◽  
Behavioral Abnormalities ◽  
Children First ◽  
And Behavior ◽  
The Impact

The implementation of a recommendation by the President’s New Freedom Commission (NFC) to screen the entire United States population—children first—for presumed, undetected, mental illness is an ill-conceived policy destined for disastrous consequences. The “pseudoscientific” methods used to screen for mental and behavioral abnormalities are a legacy from the discredited ideology of eugenics. Both eugenics and psychiatry suffer from a common philosophical fallacy that undermines the validity of their theories and prescriptions. Both are wed to a faith-based ideological assumption that mental and behavior manifestations are biologically determined, and are, therefore, ameliorated by biological interventions. NFC promoted the Texas Medication Algorithm Project (TMAP) as a “model” medication treatment plan. The impact of TMAP is evident in the skyrocketing increase in psychotropic drug prescriptions for children and adults, and in the disproportionate expenditure for psychotropic drugs. The New Freedom Commission’s screening for mental illness initiative is, therefore, but the first step toward prescribing drugs. The escalating expenditure for psychotropic drugs since TMAP leaves little doubt about who the beneficiaries of TMAP are. Screening for mental illness will increase their use.

scholarly journals Impact of Ethno-Cultural Beliefs On A Person With Mental Illness: A Case Report

2014 ◽  
Vol 3 (1) ◽  
pp. 45-47
Author(s):  
N Rajbhandari ◽  
DR Shakya ◽  
N Sapkota ◽  
M Basnet
Keyword(s):  
Mental Illness ◽  
Case Report ◽  
Social Development ◽  
Temporal Lobe ◽  
Cultural Beliefs ◽  
Proper Treatment ◽  
Significant Delay ◽  
Left Temporal Lobe ◽  
Temporal Lobe Lesion

Culture, though difficult to define, is a collection of beliefs, attitudes, knowledge, customs, habits and behaviour which influence cognitions and social development of a patient. Cultures determine how sickness and illness are defined and that will determine what the first port of call is. It also colors the psychopathology. We here describe a case of a 36 years woman who presented with psychosis which co-occurred with left temporal lobe lesion who had significant delay in receiving proper treatment because of the ethno-cultural beliefs.DOI: http://dx.doi.org/10.3126/jpan.v3i1.11353 J Psychiatrists’ Association of Nepal Vol .3, No.1, 2014: 45-47

Randomized trial protocol of bridge intervention for patients with serious mental illness and cancer.

2018 ◽  
Vol 36 (34_suppl) ◽  
pp. 153-153
Author(s):  
Lauren Fields ◽  
Catherine A Callaway ◽  
Elyse R. Park ◽  
Andrew A Nierenberg ◽  
Joseph Greer ◽  
...  
Keyword(s):  
Mental Illness ◽  
Serious Mental Illness ◽  
Cancer Care ◽  
Treatment Plan ◽  
Controlled Trial ◽  
Case Manager ◽  
Premature Mortality ◽  
Integrated Treatment ◽  
Head Neck Cancer ◽  
The Impact

153 Background: Individuals with serious mental illness (SMI) diagnosed with cancer often have disruptions in treatment, leading to premature mortality compared to patients without SMI. To address such gaps in care, we developed and piloted a collaborative care intervention for patients with SMI and cancer (Bridge). We now propose a randomized controlled trial (RCT) to investigate the impact of the Bridge intervention on disruptions in cancer care for patients with SMI. Methods: We will conduct a two-arm RCT (n = 120) comparing Bridge to enhanced usual care (EUC) for patients with SMI (schizophrenia, bipolar disorder, major depressive disorder) and newly diagnosed breast, lung, gastrointestinal, or head/neck cancer. The 12-week Bridge intervention includes: 1) assessment by a psychiatrist with expertise in oncology at cancer diagnosis, 2) involvement of a case manager to promote self-management and care coordination, 3) collaboration between psychiatry and oncology (e.g., joint visits, developing an integrated treatment plan) to address barriers to care, and 4) availability of study clinicians via phone, text, or in-person for consultation and follow-up with patients, caregivers, and oncology and community mental health clinicians. In the EUC arm, study staff will inform the treating oncologist of the psychiatric diagnosis and notify the patient and oncologist of available psychosocial services at enrollment. Patients will be randomized 1:1 to Bridge or EUC, stratified by presence of a caregiver. Identified caregivers will be co-enrolled, and patients without a caregiver will be eligible. We will utilize verbal consent, link study visits to oncology appointments, and personalize frequency and location (e.g., community, clinic, hospital) of contact with patients and caregivers to decrease burden and promote engagement. The primary outcome is the proportion of patients with disruptions in cancer care within 6 months of enrollment, confirmed by oncologists blinded to study arm. Secondary outcomes include clinician assessment of psychiatric illness severity as well as patient and caregiver reported measures (e.g., depression, engagement in care, treatment satisfaction). Results: N/A. Conclusions: N/A. Clinical trial information: NCT03360695.

Sign in / Sign up

Export Citation Format

Share Document